Else Beth Trautner
Chief Executive Officer at Euro-Diagnostica AB
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Carl Erik Mathias Uhlén | M | 70 |
Atlas Antibodies AB
Atlas Antibodies AB BiotechnologyHealth Technology Atlas Antibodies AB develops antibodies and reagents for Mass Spectrometry (MS)-based quantitative proteomics. Its project Human Protein Atlas aim to present an expression map of the complete human proteome. It offers characterized antibodies to various protein coding human genes; Triple A Polyclonals that are research grade rabbit polyclonal antibodies; and mouse monoclonal antibodies to selected proteins, as a complement to rabbit polyclonal antibodies. Its antibodies are used to study human proteins, for basic research purposes and clinical research in various disease areas, such as cancer and neurological brain diseases. The company was founded by Jan Fredrik Pontén, Karin Marianne Hansson, Henrik Wernérus, and Carl Erik Mathias Uhlén in 2006 and is headquartered in Stockholm, Sweden. | 18 years |
Torben Vedel Stahl Jörgensen | M | 72 |
Atlas Antibodies AB
Atlas Antibodies AB BiotechnologyHealth Technology Atlas Antibodies AB develops antibodies and reagents for Mass Spectrometry (MS)-based quantitative proteomics. Its project Human Protein Atlas aim to present an expression map of the complete human proteome. It offers characterized antibodies to various protein coding human genes; Triple A Polyclonals that are research grade rabbit polyclonal antibodies; and mouse monoclonal antibodies to selected proteins, as a complement to rabbit polyclonal antibodies. Its antibodies are used to study human proteins, for basic research purposes and clinical research in various disease areas, such as cancer and neurological brain diseases. The company was founded by Jan Fredrik Pontén, Karin Marianne Hansson, Henrik Wernérus, and Carl Erik Mathias Uhlén in 2006 and is headquartered in Stockholm, Sweden. | 18 years |
Sten Jörgen Wieslander | M | 74 |
Euro-Diagnostica AB
Euro-Diagnostica AB Pharmaceuticals: MajorHealth Technology Euro-Diagnostica AB provides autoimmunity testing and diagnostic solutions. It facilitates the development of safe and efficient drugs and optimal treatment of patients by providing cutting edge assays. The firm also provides clinical labs and physicians with tools to aid in diagnosis, prognosis, monitoring, and treatment of inflammatory and related diseases. The company was founded in 1992 and is headquartered in Malmo, Sweden. | - |
Tore Trulsson | M | - |
Euro-Diagnostica AB
Euro-Diagnostica AB Pharmaceuticals: MajorHealth Technology Euro-Diagnostica AB provides autoimmunity testing and diagnostic solutions. It facilitates the development of safe and efficient drugs and optimal treatment of patients by providing cutting edge assays. The firm also provides clinical labs and physicians with tools to aid in diagnosis, prognosis, monitoring, and treatment of inflammatory and related diseases. The company was founded in 1992 and is headquartered in Malmo, Sweden. | - |
Erling Lennart Johansson | M | 69 |
Atlas Antibodies AB
Atlas Antibodies AB BiotechnologyHealth Technology Atlas Antibodies AB develops antibodies and reagents for Mass Spectrometry (MS)-based quantitative proteomics. Its project Human Protein Atlas aim to present an expression map of the complete human proteome. It offers characterized antibodies to various protein coding human genes; Triple A Polyclonals that are research grade rabbit polyclonal antibodies; and mouse monoclonal antibodies to selected proteins, as a complement to rabbit polyclonal antibodies. Its antibodies are used to study human proteins, for basic research purposes and clinical research in various disease areas, such as cancer and neurological brain diseases. The company was founded by Jan Fredrik Pontén, Karin Marianne Hansson, Henrik Wernérus, and Carl Erik Mathias Uhlén in 2006 and is headquartered in Stockholm, Sweden. | - |
Charlotta Ljungqvist | M | 63 |
Atlas Antibodies AB
Atlas Antibodies AB BiotechnologyHealth Technology Atlas Antibodies AB develops antibodies and reagents for Mass Spectrometry (MS)-based quantitative proteomics. Its project Human Protein Atlas aim to present an expression map of the complete human proteome. It offers characterized antibodies to various protein coding human genes; Triple A Polyclonals that are research grade rabbit polyclonal antibodies; and mouse monoclonal antibodies to selected proteins, as a complement to rabbit polyclonal antibodies. Its antibodies are used to study human proteins, for basic research purposes and clinical research in various disease areas, such as cancer and neurological brain diseases. The company was founded by Jan Fredrik Pontén, Karin Marianne Hansson, Henrik Wernérus, and Carl Erik Mathias Uhlén in 2006 and is headquartered in Stockholm, Sweden. | 9 years |
Ronald Eric Long | M | 77 |
Euro-Diagnostica AB
Euro-Diagnostica AB Pharmaceuticals: MajorHealth Technology Euro-Diagnostica AB provides autoimmunity testing and diagnostic solutions. It facilitates the development of safe and efficient drugs and optimal treatment of patients by providing cutting edge assays. The firm also provides clinical labs and physicians with tools to aid in diagnosis, prognosis, monitoring, and treatment of inflammatory and related diseases. The company was founded in 1992 and is headquartered in Malmo, Sweden. | 15 years |
Annika Andersson | F | - |
Euro-Diagnostica AB
Euro-Diagnostica AB Pharmaceuticals: MajorHealth Technology Euro-Diagnostica AB provides autoimmunity testing and diagnostic solutions. It facilitates the development of safe and efficient drugs and optimal treatment of patients by providing cutting edge assays. The firm also provides clinical labs and physicians with tools to aid in diagnosis, prognosis, monitoring, and treatment of inflammatory and related diseases. The company was founded in 1992 and is headquartered in Malmo, Sweden. | - |
Jeffrey David Hobbs | M | - |
Euro-Diagnostica AB
Euro-Diagnostica AB Pharmaceuticals: MajorHealth Technology Euro-Diagnostica AB provides autoimmunity testing and diagnostic solutions. It facilitates the development of safe and efficient drugs and optimal treatment of patients by providing cutting edge assays. The firm also provides clinical labs and physicians with tools to aid in diagnosis, prognosis, monitoring, and treatment of inflammatory and related diseases. The company was founded in 1992 and is headquartered in Malmo, Sweden. | - |
Susanne Elisabeth Nuorti | F | 49 |
Euro-Diagnostica AB
Euro-Diagnostica AB Pharmaceuticals: MajorHealth Technology Euro-Diagnostica AB provides autoimmunity testing and diagnostic solutions. It facilitates the development of safe and efficient drugs and optimal treatment of patients by providing cutting edge assays. The firm also provides clinical labs and physicians with tools to aid in diagnosis, prognosis, monitoring, and treatment of inflammatory and related diseases. The company was founded in 1992 and is headquartered in Malmo, Sweden. | - |
Erik Henricus Maria Schropp | M | - |
Euro-Diagnostica AB
Euro-Diagnostica AB Pharmaceuticals: MajorHealth Technology Euro-Diagnostica AB provides autoimmunity testing and diagnostic solutions. It facilitates the development of safe and efficient drugs and optimal treatment of patients by providing cutting edge assays. The firm also provides clinical labs and physicians with tools to aid in diagnosis, prognosis, monitoring, and treatment of inflammatory and related diseases. The company was founded in 1992 and is headquartered in Malmo, Sweden. | - |
Louise Kores | F | - |
Atlas Antibodies AB
Atlas Antibodies AB BiotechnologyHealth Technology Atlas Antibodies AB develops antibodies and reagents for Mass Spectrometry (MS)-based quantitative proteomics. Its project Human Protein Atlas aim to present an expression map of the complete human proteome. It offers characterized antibodies to various protein coding human genes; Triple A Polyclonals that are research grade rabbit polyclonal antibodies; and mouse monoclonal antibodies to selected proteins, as a complement to rabbit polyclonal antibodies. Its antibodies are used to study human proteins, for basic research purposes and clinical research in various disease areas, such as cancer and neurological brain diseases. The company was founded by Jan Fredrik Pontén, Karin Marianne Hansson, Henrik Wernérus, and Carl Erik Mathias Uhlén in 2006 and is headquartered in Stockholm, Sweden. | - |
Sophia Hober | M | - |
Atlas Antibodies AB
Atlas Antibodies AB BiotechnologyHealth Technology Atlas Antibodies AB develops antibodies and reagents for Mass Spectrometry (MS)-based quantitative proteomics. Its project Human Protein Atlas aim to present an expression map of the complete human proteome. It offers characterized antibodies to various protein coding human genes; Triple A Polyclonals that are research grade rabbit polyclonal antibodies; and mouse monoclonal antibodies to selected proteins, as a complement to rabbit polyclonal antibodies. Its antibodies are used to study human proteins, for basic research purposes and clinical research in various disease areas, such as cancer and neurological brain diseases. The company was founded by Jan Fredrik Pontén, Karin Marianne Hansson, Henrik Wernérus, and Carl Erik Mathias Uhlén in 2006 and is headquartered in Stockholm, Sweden. | 7 years |
John Daicic | M | - |
Atlas Antibodies AB
Atlas Antibodies AB BiotechnologyHealth Technology Atlas Antibodies AB develops antibodies and reagents for Mass Spectrometry (MS)-based quantitative proteomics. Its project Human Protein Atlas aim to present an expression map of the complete human proteome. It offers characterized antibodies to various protein coding human genes; Triple A Polyclonals that are research grade rabbit polyclonal antibodies; and mouse monoclonal antibodies to selected proteins, as a complement to rabbit polyclonal antibodies. Its antibodies are used to study human proteins, for basic research purposes and clinical research in various disease areas, such as cancer and neurological brain diseases. The company was founded by Jan Fredrik Pontén, Karin Marianne Hansson, Henrik Wernérus, and Carl Erik Mathias Uhlén in 2006 and is headquartered in Stockholm, Sweden. | 7 years |
Anna Renglin Lindh | M | - |
Atlas Antibodies AB
Atlas Antibodies AB BiotechnologyHealth Technology Atlas Antibodies AB develops antibodies and reagents for Mass Spectrometry (MS)-based quantitative proteomics. Its project Human Protein Atlas aim to present an expression map of the complete human proteome. It offers characterized antibodies to various protein coding human genes; Triple A Polyclonals that are research grade rabbit polyclonal antibodies; and mouse monoclonal antibodies to selected proteins, as a complement to rabbit polyclonal antibodies. Its antibodies are used to study human proteins, for basic research purposes and clinical research in various disease areas, such as cancer and neurological brain diseases. The company was founded by Jan Fredrik Pontén, Karin Marianne Hansson, Henrik Wernérus, and Carl Erik Mathias Uhlén in 2006 and is headquartered in Stockholm, Sweden. | 4 years |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Henrik Everberg | M | - |
Atlas Antibodies AB
Atlas Antibodies AB BiotechnologyHealth Technology Atlas Antibodies AB develops antibodies and reagents for Mass Spectrometry (MS)-based quantitative proteomics. Its project Human Protein Atlas aim to present an expression map of the complete human proteome. It offers characterized antibodies to various protein coding human genes; Triple A Polyclonals that are research grade rabbit polyclonal antibodies; and mouse monoclonal antibodies to selected proteins, as a complement to rabbit polyclonal antibodies. Its antibodies are used to study human proteins, for basic research purposes and clinical research in various disease areas, such as cancer and neurological brain diseases. The company was founded by Jan Fredrik Pontén, Karin Marianne Hansson, Henrik Wernérus, and Carl Erik Mathias Uhlén in 2006 and is headquartered in Stockholm, Sweden. | 9 years |
Karin Hansson | M | 61 |
Atlas Antibodies AB
Atlas Antibodies AB BiotechnologyHealth Technology Atlas Antibodies AB develops antibodies and reagents for Mass Spectrometry (MS)-based quantitative proteomics. Its project Human Protein Atlas aim to present an expression map of the complete human proteome. It offers characterized antibodies to various protein coding human genes; Triple A Polyclonals that are research grade rabbit polyclonal antibodies; and mouse monoclonal antibodies to selected proteins, as a complement to rabbit polyclonal antibodies. Its antibodies are used to study human proteins, for basic research purposes and clinical research in various disease areas, such as cancer and neurological brain diseases. The company was founded by Jan Fredrik Pontén, Karin Marianne Hansson, Henrik Wernérus, and Carl Erik Mathias Uhlén in 2006 and is headquartered in Stockholm, Sweden. | 11 years |
Statistics
Country | Connections | % of total |
---|---|---|
Sweden | 17 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Else Beth Trautner
- Personal Network